Navigation Links
M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients
Date:10/26/2007

Knife System. The results of this study may change the way lung cancer patients are treated."

Additionally, Ritsuko Komaki, M.D., professor of Radiation Oncology and program director, Thoracic Radiation Oncology and Joe Y. Chang, M.D., Ph.D., assistant professor of Radiation Oncology and Clinical Service Chief, Thoracic Radiation Oncology, are co-principal investigators on the study.

Sites from around the world will participate in this 1,200-patient study, with coordination and oversight by the M. D. Anderson team. The goal of the study is to compare treatment outcomes between surgery and CyberKnife radiosurgery across a broad range of geographic healthcare markets. Patient accrual is expected to begin in early 2008.

A major factor in the success of this study is selecting the most accurate method of treatment that will maximize radiation to the tumor and minimize damage to surrounding healthy tissue. Accuray's CyberKnife System combined with the company's Synchrony(R) Respiratory Tracking System and Xsight(R) Lung Tumor Tracking System allow patients to receive a completely non-invasive treatment in three to four days through the precise delivery of high-dose radiation. While the patient lies comfortably and breathes normally, the CyberKnife System continually tracks the tumor to maximize targeting accuracy and minimize damage to surrounding healthy tissue. Treatments are performed in an outpatient setting, without the expected complications of an invasive surgical procedure.

"Over the past five years clinicians have obtained excellent outcomes treating lung cancer with CyberKnife Radiosurgery," said Omar Dawood, M.D., MPH, vice president of Clinical Development of Accuray Incorporated. "We believe the CyberKnife System's unique ability to track tumor motion and deliver radiation accurately and non-invasively make it the ideal platform for this clinical study. We are excited about this partnership with M. D. Anderson, a leader in cancer trea
'/>"/>

SOURCE Accuray Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
2. M. D. Anderson Cancer Center Researchers to Present CTCE-9908 Data at the AACR Annual Meeting
3. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
4. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
5. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Protox Announces Positive Clinical Data from Prostate Cancer Study
8. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
9. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
10. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
11. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "Global Multiple Sclerosis Drugs Market 2014-2018" report to ... chronic, inflammatory medical condition that results in demyelination, axonal ... of an abnormal response by the immune system, which ... is a potentially debilitating disease in which the damage ...
(Date:8/29/2014)... , Aug. 29, 2014  Pacific Medical Data ... new website design . The main website, along ... showcases the company,s new services and content relevant to ... a new streamlined design, viewers can now better understand ... health care practices and create a more visible platform ...
(Date:8/29/2014)... Research and Markets  has announced the addition of ... 2014-2018" report to their offering. ... connect, support, or surround bones. There are several types ... fascia, and other fibrous tissues. Repetitive use, accidents, injuries, ... in wear and tear in these tissues. Orthopedic soft ...
Breaking Medicine Technology:Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3PMDS Announces New Website 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3
... July 27, 2011 Reportlinker.com announces that ... in its catalogue: India ... Till 2016 http://www.reportlinker.com/p0575381/India-Cardiac-Catheters-and-Guidewires---Market-Trends-Till-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment ... This market report provides vital ...
... 26, 2011 Symmetry Medical Inc. (NYSE: SMA ... orthopaedic device industry and other medical markets, announced today that ... period ending July 2, 2011 before the market opens on ... conference call at 8:00 a.m. ET on Thursday, August 4, ...
Cached Medicine Technology:India Cardiac Catheters and Guidewires - Market Trends Till 2016 2India Cardiac Catheters and Guidewires - Market Trends Till 2016 3Symmetry Medical to Report Second Quarter 2011 Financial Results on August 4, 2011 2
(Date:8/31/2014)... 2014 NutriGold announces that its ... organic fruits and berries, has been approved ... tested, including purity and label claims. , ... Acid from genetically modified and chemically produced corn ... process involves the use of a genetically modified ...
(Date:8/31/2014)... 2014 Market Research Report on ... is a professional and in-depth market survey on ... report firstly reviews the basic information of Cell ... technology. , The report then explores global and ... their product specification, capacity, production value, and market ...
(Date:8/31/2014)... finds that invisible blood in urine may be an early ... for clinicians. , Scientists at the University of Exeter ... age of 60 who had invisible blood in their urine ... bladder cancer. The figure was around half those who had ... of bladder cancer. However, it was still higher than figures ...
(Date:8/31/2014)... August 31, 2014 Adults in the U.S. ... insurance coverage can now use the Quotes Pros website as ... this year can help consumers to find and compare costs ... use of the search tool this year is expected to ... different coverage plans at various price points. The strength of ...
(Date:8/31/2014)... 2014 According to an article posted in ... Times Stronger than Heroin , a new opiate has begun ... more potent than heroin. Known as acetyl fentanyl, this opiate ... many overdoses and emergency room visits among opiate addicts because ... individual might demonstrate the signs of a heroin overdose, they ...
Breaking Medicine News(10 mins):Health News:NutriGold’s Organic Wholefood-Sourced Vitamin C Gets ConsumerLab’s Seal of Approval 2Health News:NutriGold’s Organic Wholefood-Sourced Vitamin C Gets ConsumerLab’s Seal of Approval 3Health News:Cell Harvesting System Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Cell Harvesting System Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Cell Harvesting System Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:Invisible blood in urine may indicate bladder cancer 2Health News:Life Insurance Quotes Tool Installed for Public Use at New Insurer Portal Website 2Health News:New Street Drug Found to be Much More Powerful Than Heroin 2Health News:New Street Drug Found to be Much More Powerful Than Heroin 3
... Brompton and Harefield NHS Trust,s Leadership Role in the Treatment ... ... Stereotaxis, Inc. (Nasdaq:,STXS) announced that British Prime Minister Gordon Brown presided ... lab at,Royal Brompton Hospital in London. The new lab features Stereotaxis ...
... Federal Rule Changes ... Tools, CHICAGO, June 24 Allscripts, the ... physicians use,to improve healthcare, announced today that it ... Hospital Presbyterian in Newport Beach,Calif. preferred pricing on ...
... Go Healthy, Inc. (Pink,Sheets: GOHE) announced today that ... based in Myakka, Florida. Under the terms of,the agreement, ... marketing and,sales related services designed to bring awareness of ... specifics outlined in the agreement,are as follows:, -- ...
... on Top Industry ... Challenges, LAS ... change, healthcare chief financial officers feel the need to,anticipate change and begin ... CFOs face daunting challenges,and their insights on the state of the industry ...
... SARASOTA, Fla., June 24 The following statement was,issued today ... no convincing evidence that early screening,detection, and treatment improve ... include potential adverse health ... and treatment side effects." Policy Statement from ...
... the open-access journal PLoS Neglected Tropical Diseases ... Asia, and Latin America are also occurring frequently among ... and children. These diseases the "neglected infections ... parasitic, bacterial, and congenital infections. , While most ...
Cached Medicine News:Health News:London's Royal Brompton Hospital Opens New Electrophysiology Lab With State of the Art Magnetic Technology to Treat Arrhythmias 2Health News:London's Royal Brompton Hospital Opens New Electrophysiology Lab With State of the Art Magnetic Technology to Treat Arrhythmias 3Health News:Hoag Memorial Hospital Presbyterian Selects Allscripts for Electronic Health Record Subsidy Program 2Health News:Hoag Memorial Hospital Presbyterian Selects Allscripts for Electronic Health Record Subsidy Program 3Health News:Go Healthy Signs Marketing Contract with AIM Marketing 2Health News:Intersection of Financial and Regulatory Forces is Broadening Roles of Healthcare CFOs 2Health News:Intersection of Financial and Regulatory Forces is Broadening Roles of Healthcare CFOs 3Health News:Diagnostic Center for Disease: Robotic Prostatectomy - A Race to Failure? 2Health News:Diagnostic Center for Disease: Robotic Prostatectomy - A Race to Failure? 3Health News:Diagnostic Center for Disease: Robotic Prostatectomy - A Race to Failure? 4Health News:'Neglected infections of poverty' in US disable hundreds of thousands of Americans annually 2
Supplied sterile in peel-open packages. Intended for one-time use....
Used for percutaneous nephrostomy. Supplied sterile in peel-open packages. Intended for one-time use....
Used for percutaneous nephrostomy. Supplied sterile in peel-open packages. Intended for one-time use....
... Olympuss extensive line of affordable, high-quality ... our high-performance light sources to provide optimal ... light weight and durable design give you ... effectively and efficiently. And each is fully-autoclavable ...
Medicine Products: